CVE-2022-30277
CVE-2022-30277 is a medium-severity vulnerability in Bd Synapsys with a CVSS 3.x base score of 5.7. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-613.
Key facts
- Severity: Medium (CVSS 3.x base score 5.7)
- CVSS v2: 3.6
- EPSS exploit prediction: 0% (13th percentile)
- Actively exploited: Not listed in CISA KEV
- Weakness: CWE-613
- Affected product: Bd Synapsys
- Published:
- Last modified:
Description
BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII).
Frequently asked questions
- What is CVE-2022-30277?
- BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII).
- How severe is CVE-2022-30277?
- CVE-2022-30277 has a CVSS 3.x base score of 5.7, rated medium severity. It is exploitable over physical access with low attack complexity, requires low privileges and user interaction. Impact on confidentiality is high, integrity high, and availability none.
- Is CVE-2022-30277 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (13th percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2022-30277?
- CVE-2022-30277 primarily affects Bd Synapsys. In total, 3 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
- How do I fix CVE-2022-30277?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
- When was CVE-2022-30277 published?
- CVE-2022-30277 was published on 2022-06-02 and last updated on 2026-06-17.
References
Affected products (3)
- cpe:2.3:a:bd:synapsys:4.20:-:*:*:*:*:*:*
- cpe:2.3:a:bd:synapsys:4.20:sr1:*:*:*:*:*:*
- cpe:2.3:a:bd:synapsys:4.30:*:*:*:*:*:*:*
Other CWE-613 (Insufficient Session Expiration) vulnerabilities
- CVE-2024-8888 — Critical (CVSS 10.0): An attacker with access to the network where CIRCUTOR Q-SMT is located in its firmware version 1.0.4, could steal the…
- CVE-2026-46455 — Critical (CVSS 9.8): Insufficient Session Expiration vulnerability in Apache Camel Keycloak Component. The camel-keycloak security helper…
- CVE-2026-21622 — Critical (CVSS 9.8): Insufficient Session Expiration vulnerability in hexpm hexpm/hexpm ('Elixir.Hexpm.Accounts.PasswordReset' module)…
- CVE-2025-59786 — Critical (CVSS 9.8): 2N Access Commander version 3.4.2 and prior improperly invalidates session tokens, allowing multiple session cookies to…
- CVE-2026-26342 — Critical (CVSS 9.8): Tattile Smart+, Vega, and Basic device families firmware versions 1.181.5 and prior implement an authentication token…
- CVE-2026-1435 — Critical (CVSS 9.8): Not properly invalidated session vulnerability in Graylog Web Interface, version 2.2.3, due to incorrect management of…
Browse all CWE-613 (Insufficient Session Expiration) vulnerabilities →